Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program

Last updated: April 25, 2025
Sponsor: Thammasat University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Herpes Simplex Infections

Shingles

Hepatitis B

Treatment

N/A

Clinical Study ID

NCT06901362
MTU-EC-SA-0-159/67
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study is a cross-sectional study. The study aims to determine the levels of immunity against hepatitis B virus and varicella-zoster virus in medical students.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Medical students

  • Age 18 years or older

Exclusion

Exclusion Criteria:

  • Known cases of hepatitis B virus infection

  • Known cases of varicella-zoster virus infection

Study Design

Total Participants: 326
Study Start date:
April 01, 2025
Estimated Completion Date:
October 31, 2025

Study Description

This study is a cross-sectional study aimed at determining the levels of immunity against the hepatitis B virus and varicella virus in medical students. Additionally, it aims to compare the rate of increase in immunity levels before and after receiving the hepatitis B and varicella-zoster vaccines in medical students. Medical students aged 18 years or older are included in the study.

Connect with a study center

  • Narongkorn Saiphoklang

    Pathumthani, 12120
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.